Use of radioimmunoscintigraphy with indium-111-labeled CYT-356 (ProstaScint) scan for evaluation of patients for salvage brachytherapy

Techniques in Urology

Volumn 6, Issue 2, 2000, Pages 146-150

  Fang, D X ^a   Stock, R G ^a   Stone, N N ^a   Krynyckyi, B R ^a   Kim, C K ^a   Machac, J ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

ProstaScint; Prostate carcinoma; Radiation therapy

Indexed keywords

CAPROMAB PENDETIDE IN 111; IODINE 125; PALLADIUM; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BONE METASTASIS; BONE SCINTISCANNING; BRACHYTHERAPY; CANCER RECURRENCE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOSCINTIGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCULT CANCER; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

AGED; AGED, 80 AND OVER; ANTIBODIES, MONOCLONAL; BIOPSY; BONE NEOPLASMS; BRACHYTHERAPY; CARCINOMA; DIAGNOSIS, DIFFERENTIAL; EVALUATION STUDIES; HUMANS; INDIUM RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATIENT SELECTION; PROSTATIC NEOPLASMS; RADIOIMMUNODETECTION; SALVAGE THERAPY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0034004947     PISSN: 10793259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)